aluates Reports

$ 0.0

Automative

Global Pet Pharmaceuticals Market Research Report 2026

Published Date: 2026-04-10

Report Code: QYRE-Auto-17O9144

Global Pet Pharmaceuticals Market Outlook 2022

BUY CHAPTERS

Global Pet Pharmaceuticals Market Research Report 2026

Code: QYRE-Auto-17O9144

Report

2026-04-10

Pages:139

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Zoetis Inc

Boehringer Ingelheim

Elanco

Virbac

Dechra Veterinary Products

Ceva

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Chopperlvya Animal Health

CAHIC

Merck

Animalcare Group

Parnell

ringpu

Jinyu Group

Kyoritsu Seiyaku

Pet Pharmaceuticals Market Size

The global Pet Pharmaceuticals market was valued at US$ 18770 million in 2025 and is anticipated to reach US$ 29940 million by 2032, at a CAGR of 7.0% from 2026 to 2032.

Pet Pharmaceuticals Market

Pet pharmaceutical refers specifically to medicines given to pets. In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved. In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.

The pet pharmaceuticals market is experiencing strong growth, driven by the rising trend of pet humanization, increasing pet ownership, and heightened awareness of animal health. As more people consider pets as part of the family, spending on veterinary care and pharmaceuticals has surged globally. Advancements in veterinary medicine have also contributed to the development of more targeted and effective drugs for chronic diseases, pain management, parasitic infections, and preventive care. Additionally, the growing elderly population and single households have led to higher demand for companion animals, further fueling the market. Pet insurance is becoming more widespread, especially in North America and Europe, making veterinary drugs more accessible and affordable to pet owners. These factors collectively boost the demand for both prescription and over-the-counter pet medications.

Despite promising growth, the pet pharmaceuticals market faces several challenges. Regulatory requirements for veterinary drugs are becoming stricter, increasing the time and cost needed for product development and approval. Additionally, counterfeit and low-quality medications, particularly in developing regions, can undermine the trust of veterinarians and pet owners. Limited availability of skilled veterinary professionals in some countries also affects the diagnosis and prescription of appropriate pharmaceutical treatments. Another barrier is the high cost of innovative pet drugs, which can deter adoption, especially among lower-income pet owners. Moreover, competition from alternative therapies and natural remedies is rising, presenting additional challenges for pharmaceutical companies to differentiate their products in an increasingly crowded marketplace.

The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.

This report delivers a comprehensive overview of the global Pet Pharmaceuticals market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pet Pharmaceuticals. The Pet Pharmaceuticals market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pet Pharmaceuticals market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pet Pharmaceuticals manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Pet Pharmaceuticals Market Report

Report Metric	Details
Report Name	Pet Pharmaceuticals Market
Accounted market size in 2025	US$ 18770 in million
Forecasted market size in 2032	US$ 29940 million
CAGR	7.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Antiparasitic Biological Products Antibacterial Others
Segment by Application	Prevention Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAHIC, Animalcare Group, Parnell, Ringpu, Jinyu Group, Kyoritsu Seiyaku
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pet Pharmaceuticals companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Pet Pharmaceuticals Market growing?

Ans: The Pet Pharmaceuticals Market witnessing a CAGR of 7.0% during the forecast period 2026-2032.

What is the Pet Pharmaceuticals Market size in 2032?

Ans: The Pet Pharmaceuticals Market size in 2032 will be US$ 29940 million.

What is the market share of major companies in Pet Pharmaceuticals Market?

Ans: The top 3 players occupy about 60% shares of the global market.

What is the Pet Pharmaceuticals Market share by type?

Ans: Antiparasitic is the main type, with a share about 30%.

What is the Pet Pharmaceuticals Market share by application?

Ans: Prevention is the main application, which holds a share about 80%.

Who are the main players in the Pet Pharmaceuticals Market report?

Ans: The main players in the Pet Pharmaceuticals Market are Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAHIC, Animalcare Group, Parnell, Ringpu, Jinyu Group, Kyoritsu Seiyaku

What are the Application segmentation covered in the Pet Pharmaceuticals Market report?

Ans: The Applications covered in the Pet Pharmaceuticals Market report are Prevention, Treatment

What are the Type segmentation covered in the Pet Pharmaceuticals Market report?

Ans: The Types covered in the Pet Pharmaceuticals Market report are Antiparasitic, Biological Products, Antibacterial, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pet Pharmaceuticals Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Antiparasitic

1.2.3 Biological Products

1.2.4 Antibacterial

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pet Pharmaceuticals Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Prevention

1.3.3 Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pet Pharmaceuticals Market Perspective (2021–2032)

2.2 Global Pet Pharmaceuticals Growth Trends by Region

2.2.1 Global Pet Pharmaceuticals Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Pet Pharmaceuticals Historic Market Size by Region (2021–2026)

2.2.3 Pet Pharmaceuticals Forecasted Market Size by Region (2027–2032)

2.3 Pet Pharmaceuticals Market Dynamics

2.3.1 Pet Pharmaceuticals Industry Trends

2.3.2 Pet Pharmaceuticals Market Drivers

2.3.3 Pet Pharmaceuticals Market Challenges

2.3.4 Pet Pharmaceuticals Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pet Pharmaceuticals Players by Revenue

3.1.1 Global Top Pet Pharmaceuticals Players by Revenue (2021–2026)

3.1.2 Global Pet Pharmaceuticals Revenue Market Share by Players (2021–2026)

3.2 Global Top Pet Pharmaceuticals Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Pet Pharmaceuticals Revenue

3.4 Global Pet Pharmaceuticals Market Concentration Ratio

3.4.1 Global Pet Pharmaceuticals Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pet Pharmaceuticals Revenue in 2025

3.5 Global Key Players of Pet Pharmaceuticals Head Offices and Areas Served

3.6 Global Key Players of Pet Pharmaceuticals, Products and Applications

3.7 Global Key Players of Pet Pharmaceuticals, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Pet Pharmaceuticals Breakdown Data by Type

4.1 Global Pet Pharmaceuticals Historic Market Size by Type (2021–2026)

4.2 Global Pet Pharmaceuticals Forecasted Market Size by Type (2027–2032)

5 Pet Pharmaceuticals Breakdown Data by Application

5.1 Global Pet Pharmaceuticals Historic Market Size by Application (2021–2026)

5.2 Global Pet Pharmaceuticals Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Pet Pharmaceuticals Market Size (2021–2032)

6.2 North America Pet Pharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Pet Pharmaceuticals Market Size by Country (2021–2026)

6.4 North America Pet Pharmaceuticals Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pet Pharmaceuticals Market Size (2021–2032)

7.2 Europe Pet Pharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Pet Pharmaceuticals Market Size by Country (2021–2026)

7.4 Europe Pet Pharmaceuticals Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Pet Pharmaceuticals Market Size (2021–2032)

8.2 Asia-Pacific Pet Pharmaceuticals Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Pet Pharmaceuticals Market Size by Region (2021–2026)

8.4 Asia-Pacific Pet Pharmaceuticals Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Pet Pharmaceuticals Market Size (2021–2032)

9.2 Latin America Pet Pharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Pet Pharmaceuticals Market Size by Country (2021–2026)

9.4 Latin America Pet Pharmaceuticals Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pet Pharmaceuticals Market Size (2021–2032)

10.2 Middle East & Africa Pet Pharmaceuticals Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Pet Pharmaceuticals Market Size by Country (2021–2026)

10.4 Middle East & Africa Pet Pharmaceuticals Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Zoetis

11.1.1 Zoetis Company Details

11.1.2 Zoetis Business Overview

11.1.3 Zoetis Pet Pharmaceuticals Introduction

11.1.4 Zoetis Revenue in Pet Pharmaceuticals Business (2021–2026)

11.1.5 Zoetis Recent Development

11.2 Boehringer Ingelheim

11.2.1 Boehringer Ingelheim Company Details

11.2.2 Boehringer Ingelheim Business Overview

11.2.3 Boehringer Ingelheim Pet Pharmaceuticals Introduction

11.2.4 Boehringer Ingelheim Revenue in Pet Pharmaceuticals Business (2021–2026)

11.2.5 Boehringer Ingelheim Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Pet Pharmaceuticals Introduction

11.3.4 Merck Revenue in Pet Pharmaceuticals Business (2021–2026)

11.3.5 Merck Recent Development

11.4 Elanco

11.4.1 Elanco Company Details

11.4.2 Elanco Business Overview

11.4.3 Elanco Pet Pharmaceuticals Introduction

11.4.4 Elanco Revenue in Pet Pharmaceuticals Business (2021–2026)

11.4.5 Elanco Recent Development

11.5 Virbac

11.5.1 Virbac Company Details

11.5.2 Virbac Business Overview

11.5.3 Virbac Pet Pharmaceuticals Introduction

11.5.4 Virbac Revenue in Pet Pharmaceuticals Business (2021–2026)

11.5.5 Virbac Recent Development

11.6 Dechra Veterinary Products

11.6.1 Dechra Veterinary Products Company Details

11.6.2 Dechra Veterinary Products Business Overview

11.6.3 Dechra Veterinary Products Pet Pharmaceuticals Introduction

11.6.4 Dechra Veterinary Products Revenue in Pet Pharmaceuticals Business (2021–2026)

11.6.5 Dechra Veterinary Products Recent Development

11.7 Ceva

11.7.1 Ceva Company Details

11.7.2 Ceva Business Overview

11.7.3 Ceva Pet Pharmaceuticals Introduction

11.7.4 Ceva Revenue in Pet Pharmaceuticals Business (2021–2026)

11.7.5 Ceva Recent Development

11.8 Vetoquinol

11.8.1 Vetoquinol Company Details

11.8.2 Vetoquinol Business Overview

11.8.3 Vetoquinol Pet Pharmaceuticals Introduction

11.8.4 Vetoquinol Revenue in Pet Pharmaceuticals Business (2021–2026)

11.8.5 Vetoquinol Recent Development

11.9 Ouro Fino Saude

11.9.1 Ouro Fino Saude Company Details

11.9.2 Ouro Fino Saude Business Overview

11.9.3 Ouro Fino Saude Pet Pharmaceuticals Introduction

11.9.4 Ouro Fino Saude Revenue in Pet Pharmaceuticals Business (2021–2026)

11.9.5 Ouro Fino Saude Recent Development

11.10 Norbrook

11.10.1 Norbrook Company Details

11.10.2 Norbrook Business Overview

11.10.3 Norbrook Pet Pharmaceuticals Introduction

11.10.4 Norbrook Revenue in Pet Pharmaceuticals Business (2021–2026)

11.10.5 Norbrook Recent Development

11.11 Jindun

11.11.1 Jindun Company Details

11.11.2 Jindun Business Overview

11.11.3 Jindun Pet Pharmaceuticals Introduction

11.11.4 Jindun Revenue in Pet Pharmaceuticals Business (2021–2026)

11.11.5 Jindun Recent Development

11.12 Chopperlvya Animal Health

11.12.1 Chopperlvya Animal Health Company Details

11.12.2 Chopperlvya Animal Health Business Overview

11.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Introduction

11.12.4 Chopperlvya Animal Health Revenue in Pet Pharmaceuticals Business (2021–2026)

11.12.5 Chopperlvya Animal Health Recent Development

11.13 CAHIC

11.13.1 CAHIC Company Details

11.13.2 CAHIC Business Overview

11.13.3 CAHIC Pet Pharmaceuticals Introduction

11.13.4 CAHIC Revenue in Pet Pharmaceuticals Business (2021–2026)

11.13.5 CAHIC Recent Development

11.14 Animalcare Group

11.14.1 Animalcare Group Company Details

11.14.2 Animalcare Group Business Overview

11.14.3 Animalcare Group Pet Pharmaceuticals Introduction

11.14.4 Animalcare Group Revenue in Pet Pharmaceuticals Business (2021–2026)

11.14.5 Animalcare Group Recent Development

11.15 Parnell

11.15.1 Parnell Company Details

11.15.2 Parnell Business Overview

11.15.3 Parnell Pet Pharmaceuticals Introduction

11.15.4 Parnell Revenue in Pet Pharmaceuticals Business (2021–2026)

11.15.5 Parnell Recent Development

11.16 Ringpu

11.16.1 Ringpu Company Details

11.16.2 Ringpu Business Overview

11.16.3 Ringpu Pet Pharmaceuticals Introduction

11.16.4 Ringpu Revenue in Pet Pharmaceuticals Business (2021–2026)

11.16.5 Ringpu Recent Development

11.17 Jinyu Group

11.17.1 Jinyu Group Company Details

11.17.2 Jinyu Group Business Overview

11.17.3 Jinyu Group Pet Pharmaceuticals Introduction

11.17.4 Jinyu Group Revenue in Pet Pharmaceuticals Business (2021–2026)

11.17.5 Jinyu Group Recent Development

11.18 Kyoritsu Seiyaku

11.18.1 Kyoritsu Seiyaku Company Details

11.18.2 Kyoritsu Seiyaku Business Overview

11.18.3 Kyoritsu Seiyaku Pet Pharmaceuticals Introduction

11.18.4 Kyoritsu Seiyaku Revenue in Pet Pharmaceuticals Business (2021–2026)

11.18.5 Kyoritsu Seiyaku Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Zoetis Inc

Boehringer Ingelheim

Elanco

Virbac

Dechra Veterinary Products

Ceva

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Chopperlvya Animal Health

CAHIC

Merck

Animalcare Group

Parnell

ringpu

Jinyu Group

Kyoritsu Seiyaku

List of Tables

Table 1. Global Pet Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Antiparasitic

Table 3. Key Players of Biological Products

Table 4. Key Players of Antibacterial

Table 5. Key Players of Others

Table 6. Global Pet Pharmaceuticals Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Pet Pharmaceuticals Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Pet Pharmaceuticals Market Size by Region (US$ Million), 2021–2026

Table 9. Global Pet Pharmaceuticals Market Share by Region (2021–2026)

Table 10. Global Pet Pharmaceuticals Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Pet Pharmaceuticals Market Share by Region (2027–2032)

Table 12. Pet Pharmaceuticals Market Trends

Table 13. Pet Pharmaceuticals Market Drivers

Table 14. Pet Pharmaceuticals Market Challenges

Table 15. Pet Pharmaceuticals Market Restraints

Table 16. Global Pet Pharmaceuticals Revenue by Players (US$ Million), 2021–2026

Table 17. Global Pet Pharmaceuticals Market Share by Players (2021–2026)

Table 18. Global Top Pet Pharmaceuticals Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pet Pharmaceuticals Revenue, 2025

Table 19. Ranking of Global Top Pet Pharmaceuticals Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Pet Pharmaceuticals Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Pet Pharmaceuticals, Headquarters and Area Served

Table 22. Global Key Players of Pet Pharmaceuticals, Products and Applications

Table 23. Global Key Players of Pet Pharmaceuticals, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Pet Pharmaceuticals Market Size by Type (US$ Million), 2021–2026

Table 26. Global Pet Pharmaceuticals Revenue Market Share by Type (2021–2026)

Table 27. Global Pet Pharmaceuticals Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Pet Pharmaceuticals Revenue Market Share by Type (2027–2032)

Table 29. Global Pet Pharmaceuticals Market Size by Application (US$ Million), 2021–2026

Table 30. Global Pet Pharmaceuticals Revenue Market Share by Application (2021–2026)

Table 31. Global Pet Pharmaceuticals Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Pet Pharmaceuticals Revenue Market Share by Application (2027–2032)

Table 33. North America Pet Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Pet Pharmaceuticals Market Size by Country (US$ Million), 2021–2026

Table 35. North America Pet Pharmaceuticals Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Pet Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Pet Pharmaceuticals Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Pet Pharmaceuticals Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Pet Pharmaceuticals Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Pet Pharmaceuticals Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Pet Pharmaceuticals Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Pet Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Pet Pharmaceuticals Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Pet Pharmaceuticals Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Pet Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Pet Pharmaceuticals Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Pet Pharmaceuticals Market Size by Country (US$ Million), 2027–2032

Table 48. Zoetis Company Details

Table 49. Zoetis Business Overview

Table 50. Zoetis Pet Pharmaceuticals Product

Table 51. Zoetis Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 52. Zoetis Recent Development

Table 53. Boehringer Ingelheim Company Details

Table 54. Boehringer Ingelheim Business Overview

Table 55. Boehringer Ingelheim Pet Pharmaceuticals Product

Table 56. Boehringer Ingelheim Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 57. Boehringer Ingelheim Recent Development

Table 58. Merck Company Details

Table 59. Merck Business Overview

Table 60. Merck Pet Pharmaceuticals Product

Table 61. Merck Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 62. Merck Recent Development

Table 63. Elanco Company Details

Table 64. Elanco Business Overview

Table 65. Elanco Pet Pharmaceuticals Product

Table 66. Elanco Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 67. Elanco Recent Development

Table 68. Virbac Company Details

Table 69. Virbac Business Overview

Table 70. Virbac Pet Pharmaceuticals Product

Table 71. Virbac Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 72. Virbac Recent Development

Table 73. Dechra Veterinary Products Company Details

Table 74. Dechra Veterinary Products Business Overview

Table 75. Dechra Veterinary Products Pet Pharmaceuticals Product

Table 76. Dechra Veterinary Products Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 77. Dechra Veterinary Products Recent Development

Table 78. Ceva Company Details

Table 79. Ceva Business Overview

Table 80. Ceva Pet Pharmaceuticals Product

Table 81. Ceva Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 82. Ceva Recent Development

Table 83. Vetoquinol Company Details

Table 84. Vetoquinol Business Overview

Table 85. Vetoquinol Pet Pharmaceuticals Product

Table 86. Vetoquinol Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 87. Vetoquinol Recent Development

Table 88. Ouro Fino Saude Company Details

Table 89. Ouro Fino Saude Business Overview

Table 90. Ouro Fino Saude Pet Pharmaceuticals Product

Table 91. Ouro Fino Saude Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 92. Ouro Fino Saude Recent Development

Table 93. Norbrook Company Details

Table 94. Norbrook Business Overview

Table 95. Norbrook Pet Pharmaceuticals Product

Table 96. Norbrook Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 97. Norbrook Recent Development

Table 98. Jindun Company Details

Table 99. Jindun Business Overview

Table 100. Jindun Pet Pharmaceuticals Product

Table 101. Jindun Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 102. Jindun Recent Development

Table 103. Chopperlvya Animal Health Company Details

Table 104. Chopperlvya Animal Health Business Overview

Table 105. Chopperlvya Animal Health Pet Pharmaceuticals Product

Table 106. Chopperlvya Animal Health Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 107. Chopperlvya Animal Health Recent Development

Table 108. CAHIC Company Details

Table 109. CAHIC Business Overview

Table 110. CAHIC Pet Pharmaceuticals Product

Table 111. CAHIC Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 112. CAHIC Recent Development

Table 113. Animalcare Group Company Details

Table 114. Animalcare Group Business Overview

Table 115. Animalcare Group Pet Pharmaceuticals Product

Table 116. Animalcare Group Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 117. Animalcare Group Recent Development

Table 118. Parnell Company Details

Table 119. Parnell Business Overview

Table 120. Parnell Pet Pharmaceuticals Product

Table 121. Parnell Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 122. Parnell Recent Development

Table 123. Ringpu Company Details

Table 124. Ringpu Business Overview

Table 125. Ringpu Pet Pharmaceuticals Product

Table 126. Ringpu Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 127. Ringpu Recent Development

Table 128. Jinyu Group Company Details

Table 129. Jinyu Group Business Overview

Table 130. Jinyu Group Pet Pharmaceuticals Product

Table 131. Jinyu Group Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 132. Jinyu Group Recent Development

Table 133. Kyoritsu Seiyaku Company Details

Table 134. Kyoritsu Seiyaku Business Overview

Table 135. Kyoritsu Seiyaku Pet Pharmaceuticals Product

Table 136. Kyoritsu Seiyaku Revenue in Pet Pharmaceuticals Business (US$ Million), 2021–2026

Table 137. Kyoritsu Seiyaku Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Pet Pharmaceuticals Picture

Figure 2. Global Pet Pharmaceuticals Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Pet Pharmaceuticals Market Share by Type: 2025 vs 2032

Figure 4. Antiparasitic Features

Figure 5. Biological Products Features

Figure 6. Antibacterial Features

Figure 7. Others Features

Figure 8. Global Pet Pharmaceuticals Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Pet Pharmaceuticals Market Share by Application: 2025 vs 2032

Figure 10. Prevention Case Studies

Figure 11. Treatment Case Studies

Figure 12. Pet Pharmaceuticals Report Years Considered

Figure 13. Global Pet Pharmaceuticals Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Pet Pharmaceuticals Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Pet Pharmaceuticals Market Share by Region: 2025 vs 2032

Figure 16. Global Pet Pharmaceuticals Market Share by Players in 2025

Figure 17. Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Pet Pharmaceuticals Revenue in 2025

Figure 19. North America Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Pet Pharmaceuticals Market Share by Country (2021–2032)

Figure 21. United States Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Pet Pharmaceuticals Market Share by Country (2021–2032)

Figure 25. Germany Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Pet Pharmaceuticals Market Share by Region (2021–2032)

Figure 33. China Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Pet Pharmaceuticals Market Share by Country (2021–2032)

Figure 41. Mexico Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Pet Pharmaceuticals Market Share by Country (2021–2032)

Figure 45. Israel Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Pet Pharmaceuticals Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Zoetis Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 49. Boehringer Ingelheim Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 50. Merck Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 51. Elanco Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 52. Virbac Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 53. Dechra Veterinary Products Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 54. Ceva Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 55. Vetoquinol Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 56. Ouro Fino Saude Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 57. Norbrook Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 58. Jindun Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 59. Chopperlvya Animal Health Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 60. CAHIC Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 61. Animalcare Group Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 62. Parnell Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 63. Ringpu Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 64. Jinyu Group Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 65. Kyoritsu Seiyaku Revenue Growth Rate in Pet Pharmaceuticals Business (2021–2026)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Preventive Medicine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antimicrobials for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Insecticide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti inflammatory Medicine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Intestinal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Companion Animal Drug Market Research Report 2024

Global Pet Veterinary Drug Market Insights Forecast to 2030

Pet Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pet Antibiotic Market Research Report 2025

Pet Drug and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Drugs for Companion Animals Market Research Report 2025

Pet Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Companion Animal Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Speciality Drugs Market

Global Pet Medicine Market Insights Forecast to 2030

OTC Pet Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pet Therapeutics Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions